Related Experiment Videos
Apoptosis in caspase-inhibited neurons
C Volbracht1, M Leist, S A Kolb
1Department of Biology, University of Konstanz, Germany.
Molecular Medicine (Cambridge, Mass.)
|July 28, 2001
Summary
Neurodegenerative diseases involve neuronal loss and axodendritic network degeneration. Caspase inhibition only partially rescues damaged neurons, as apoptosis-like features persist, suggesting complex cell death pathways.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Growing evidence links apoptosis to neurodegenerative diseases.
- The precise mechanisms of neuronal loss and axodendritic network degeneration in these diseases remain unclear.
- It is not fully understood if caspases are solely responsible for neuronal apoptosis.
Purpose of the Study:
- To investigate the roles of Bcl-2 and caspases in neurite degeneration and neuronal soma death.
- To elucidate the mechanisms underlying neuronal cell death in response to axodendritic network disruption.
Main Methods:
- Utilized long-term colchicine exposure to disrupt the axodendritic network in cerebellar granule cell cultures.
- Examined the involvement of Bcl-2 and caspases in mediating apoptosis.
- Assessed the effects of caspase inhibition (zVAD-fmk) and proteasome inhibitors on neuronal death.
Main Results:
- Early axodendritic network degeneration proceeded independently of Bcl-2 and caspases.
- Bcl-2 delayed, and caspase inhibition initially blocked, cell body apoptosis.
- Complete caspase blockade did not prevent delayed cell death, which exhibited cytochrome c release, chromatin condensation, DNA fragmentation, and phosphatidylserine exposure.
- Proteasome inhibitors mitigated these caspase-independent apoptotic features.
Conclusions:
- Bcl-2-dependent and caspase-mediated pathways only partially explain neurodegeneration in injured neurons.
- Caspase inhibition offers only temporary rescue, with apoptosis-like features emerging independently.
- These findings highlight complex, multifaceted cell death mechanisms in neurodegeneration beyond classical caspase-driven apoptosis.